BIOL (Biolase, Inc.) Company Projected Revenue

Brandmark of Biolase, Inc. (BIOL)

The Waterlase ecosystem ties clinics to the brand's consumables, supporting the expected sales volume for BIOLASE, Inc. (BIOL). This chart illustrates a search for a bottom, where the 0.05 mark serves as the current indicator. An impeccable image as a leader in dental lasers strengthens the position of BIOLASE, Inc. (BIOL), although geopolitical risks and export controls may slow the expansion of systems into foreign markets.

BIOL - Biolase Inc. Company Expected Sales Volume over the range 07/04/2022 - 08/04/2024

Analytical breakdowns and data insights for company BIOLASE Inc. (BIOL)

- current price and projected stock value:
Fundamental company analysis:BIOLASE, Inc.
Brand item of BIOLASE Inc.

BIOLASE, Inc. (BIOL), a leader in painless laser dentistry, demonstrates its expansive growth dynamics through the company's future sales levels. This indicator represents estimated revenue, updated daily based on actual transaction registries. A filtering method for random price fluctuations allows for the precise tracking of the fundamental demand trend for Waterlase technology. The stability of the curve confirms the resilience of the business model, rendering the asset investment-grade.

Analysis of competing companies

Company Future Sales Volume BSX (Boston Scientific)|EW (edwards.com) - Company Future Revenue|Company Projected Revenue ResMed RMD|PODD - Company Future Sales Volume|Zimmer - Projected Sales Volume|Company Expected Sales Volume CooperSurgical|ALGN: Projected Sales Volume|Company Revenue Forecast GMED|TMDX (TransMedics Group, Inc.) - Projected Sales Volume|Alphatec Holdings (ATEC) - Company Future Sales|Projected Sales Volume AORT|Company Future Sales Volume Enovis Inc. ENOV|Projected Sales Volume IART (Integra LifeSciences)|Projected Sales Volume establishmentlabs.com ESTA|BBNX - Company Projected Revenue|IRMD: Company Projected Revenue|EMBC (Embecta Inc.) - Company Future Sales Volume|Tandem Corp - Company Future Revenue|AXGN (AxoGen, Inc.) - Projected Sales Volume|Company Expected Sales Volume si-bone.com SIBN|Company Projected Revenue Orthofix (OFIX)|Bioventus Inc (BVS) - Company Sales Forecast|OrthoPediatrics - Company Future Sales Volume|Projected Sales Volume Treace Corp TMCI|Strata Critical Medical Inc - Projected Sales Volume|Company Future Sales carlsmed.com CARL|RxSight (RXST) - Company Projected Revenue|Company Expected Revenue CLPT (ClearPoint Neuro)|Company Projected Revenue Stereotaxis Corp|Company Future Sales Volume Neuronetics, Inc (STIM)|Projected Sales Volume SGHT|OBIO - Company Expected Sales Volume|Company Projected Revenue Anika Therapeutics, Inc. ANIK|NSPR: Company Revenue Forecast|ZJYL: Company Future Sales Volume|Vivani Medical, Inc. - Company Projected Revenue Volume|XTNT: Projected Sales Volume|NMTC (n1mtc.com) - Company Projected Revenue|MODD (Modular Medical Inc) - Projected Sales Volume|Myomo Inc. (MYO) - Company Future Sales|Company Projected Revenue Envoy Medical, Inc (COCH)|VVOS - Company Expected Sales Volume|Company Projected Revenue enVVeno Medical NVNO|Sintx Technologies Inc - Company Projected Revenue|Tenon Medical - Projected Sales Volume|LFWD - Projected Sales Volume|autonomix.com (AMIX) - Company Projected Revenue|IVF - Company Future Sales|BBLG (Bone Biologics) - Projected Sales Volume|Company Expected Sales Volume axonics.com AXNX|Company Future Sales Volume DYNT (Dynatronics Corporation)|FNA (paragon28.com) - Company Future Revenue|Projected Sales Volume INVO (INVO Bioscience)